๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Acute Leukemia in Remission

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia NCT07400029Phase 29 sites๐Ÿ“ Duarte๐Ÿ“ Stanford๐Ÿ“ Basking Ridge Memorial Sloan Kettering Cancer Center ยท Tests: Obecabtagene Autoleucel UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia NCT06245746Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo) Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML NCT06221683Phase 213 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Guangzhou Children's Hospital of Soochow University ยท Tests: Homoharringtonine, Cytarabine, Etoposide, Venetoclax, Mitoxantrone hydrochloride liposome Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Andrew E. Place, MD ยท Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Determining the Mechanisms of Loss of CAR T Cell Persistence NCT05809284n/a3 sites๐Ÿ“ London๐Ÿ“ London๐Ÿ“ Manchester University College, London Maintenance Venetoclax in AML Fit Patients NCT07244367NA2 sites๐Ÿ“ Sohag๐Ÿ“ Sohag Sohag University ยท Tests: SC cytarabine +Venetoclax Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial NCT07101588Phase 41 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Ruxolitinib, Decitabine Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 NCT05535855Phase 11 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: CD19 Directed CAR T Cell Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT NCT05917405Phase 223 sites๐Ÿ“ Nantes๐Ÿ“ Amiens๐Ÿ“ Angers Nantes University Hospital ยท Tests: Fludarabine, Busulfan, ATG, Clofarabine XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia NCT06980155EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: Personalized neoantigen tumor vaccine, PD-1 inhibitor Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX) NCT06045819n/a1 site๐Ÿ“ Caen University Hospital, Caen ยท Tests: Blood sampling for venetoclax drug dosage (venous puncture) Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission NCT06824168Phase 264 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Daiichi Sankyo ยท Tests: Quizartinib High Dose, Quizartinib Low Dose Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients NCT04314219Phase 31 site๐Ÿ“ Riyadh King Faisal Specialist Hospital & Research Center ยท Tests: Cyclophosphamide 50mg, Methotrexate Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation NCT04935684Phase 220 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Besanรงon University Hospital, Clermont-Ferrand ยท Tests: Fecal Microbiota Transplantation The Maintenance Treatment of "ITIVA" in AML Patients NCT06256627NA1 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: recombinant human interference'- ฮฑ- 1b, interleukin-2, thalidomide, Venentoclax and Azacitidine Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia NCT06034561Phase 21 site๐Ÿ“ Sรฃo Paulo Instituto do Cancer do Estado de Sรฃo Paulo ยท Tests: Bortezomib MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Registry of Older Patients With Cancer NCT01137825n/a7 sites๐Ÿ“ Boone๐Ÿ“ Chapel Hill๐Ÿ“ Greenville UNC Lineberger Comprehensive Cancer Center L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML NCT06788756Phase 2, Phase 328 sites๐Ÿ“ Birmingham๐Ÿ“ Miami๐Ÿ“ Augusta Moleculin Biotech, Inc. ยท Tests: Placebo in combination with Cytarabine Injection, Liposomal Annamycin Injection in combination with Cytarabine Injectioโ€ฆ Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission NCT07522905NA1 site๐Ÿ“ Bratislava Comenius University ยท Tests: Virtual BUDDY-Movement Therapy 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome NCT03670966Phase 1, Phase 21 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10, Cyclophosphamide, Total-Body Irradiation, Peripheral Blood Stem โ€ฆ Phase IB/II of CPX-351 for Relapse Prevention in AML NCT04990102Phase 1, Phase 23 sites๐Ÿ“ Washington D.C.๐Ÿ“ Hackensack๐Ÿ“ Philadelphia Georgetown University ยท Tests: CPX-351 MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880NA1 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi) Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia NCT07575971Phase 1, Phase 21 site๐Ÿ“ Beijing Liping Dou ยท Tests: CD22/CD19 Dual-Target CAR-T Cells Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1 NCT06718244Phase 21 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: single dose of Inaticabtagene autoleucel Ziftomenib Maintenance Post Allo-HCT NCT06440135Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Columbus Massachusetts General Hospital ยท Tests: Ziftomenib Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission NCT05909293NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Venclexta 100 MG Oral Tablet Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission. NCT07254312n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy